In the Translational Cancer Metabolism (TCM) lab we try to investigate the metabolic dependencies of cancer cells under biologically relevant conditions, such as nutrient stress, in a biomarker-specific manner. Utilising our novel 3- dimensional functional genomics pipeline we have identified novel tumour suppressors that are driving disease trajectory and treatment response. During my research in BCI I use metabolomics, proteomics and other cutting-edge platforms to dissect the metabolic architecture of cancer models that harbour alterations in these tumour suppressors.